Page Therapeutics is a Swiss preclinical-stage biotech company spun out of the ETHZ and founded on the groundbreaking science of Prof. Nicola Aceto. Page targets the vulnerabilities of tumour cells circulating in the bloodstream and is developing novel therapies that can disrupt their clusters, inhibiting their ability to form metastases.
Company Details
- Employees
- 6
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.pagetherapeutics.com
- Keywords
- Corciano.
Page Therapeutics Ag Questions
Page Therapeutics Ag's website is http://www.pagetherapeutics.com
Page Therapeutics Ag's LinkedIn profile is https://www.linkedin.com/company/page-therapeutics-ag
Page Therapeutics Ag has
6 employees.
View email and phone details for 6
employees at Page Therapeutics Ag.
Page Therapeutics Ag's industry is
Pharmaceutical Manufacturing
Page Therapeutics Ag's top competitors are
Diamante Healthcare Consulting,
Xgen Venture,
Pizeta Pharma S.p.a.,
Prolabin & Tefarm,
Novo Holdings,
Nouscom,
Tes Pharma S.r.l.,
Claris Ventures,
Molecular Horizon,
Lumacyte.
Page Therapeutics Ag's categories are Pharmaceutical Manufacturing
